.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Argus Health
Covington
Julphar
McKinsey
Cipla
Farmers Insurance
Healthtrust
Federal Trade Commission
Harvard Business School

Generated: July 26, 2017

DrugPatentWatch Database Preview

Ganciclovir - Generic Drug Details

« Back to Dashboard

What are the generic sources for ganciclovir and what is the scope of ganciclovir freedom to operate?

Ganciclovir
is the generic ingredient in three branded drugs marketed by Exela Pharma Scs Llc, West-ward Pharms Int, Luitpold Pharms Inc, Par Sterile Products, Fresenius Kabi Usa, and Roche Palo, and is included in six NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for ganciclovir. Three suppliers are listed for this compound.

Summary for Generic Name: ganciclovir

Tradenames:3
Patents:2
Applicants:6
NDAs:6
Drug Master File Entries: see list25
Suppliers / Packagers: see list3
Bulk Api Vendors: see list89
Clinical Trials: see list122
Patent Applications: see list6,406
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ganciclovir at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb
VITRASERT
ganciclovir
IMPLANT;IMPLANTATION020569-001Mar 4, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-001Dec 22, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Exela Pharma Scs Llc
GANCICLOVIR
ganciclovir
SOLUTION;IV (INFUSION)209347-001Feb 17, 2017RXYesYes► Subscribe► SubscribeY ► Subscribe
Ranbaxy Labs Ltd
GANCICLOVIR
ganciclovir
CAPSULE;ORAL076457-001Jun 27, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir sodium
INJECTABLE;INJECTION019661-001Jun 23, 1989APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ganciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-002Dec 12, 1997► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-001Dec 22, 1994► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-001Dec 22, 1994► Subscribe► Subscribe
Bausch And Lomb
VITRASERT
ganciclovir
IMPLANT;IMPLANTATION020569-001Mar 4, 1996► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-002Dec 12, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Queensland Health
Colorcon
Chubb
Medtronic
Moodys
Express Scripts
Merck
Boehringer Ingelheim
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot